AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33454705 — intervention group
Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 66
Study 35074319 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure (n=52)
Number of subjects: 112
Study 35074319 — intervention group
Group type: COMPARATOR
Intervention: Control (n=60)
Number of subjects: 112
Study 33960064 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher income (adjusted odds ratio (AOR) = 0.299)
Number of subjects: 823
Study 33960064 — intervention group
Group type: EXPERIMENTAL
Intervention: Being physically active
Number of subjects: 823
Study 33960064 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical disability (AOR = 3.03)
Number of subjects: 823
Study 33960064 — intervention group
Group type: EXPERIMENTAL
Intervention: High level of loneliness (AOR = 41.76)
Number of subjects: 823
Study 33960064 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily or occasional physical activity (AOR = 0.35; AOR = 0.50)
Number of subjects: 823
Study 33960064 — intervention group
Group type: EXPERIMENTAL
Intervention: Digestive symptoms (AOR = 1.98)
Number of subjects: 823
Study 33960064 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor nutritional status (AOR = 1.99)
Number of subjects: 823
Study 33960064 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong feelings of loneliness (AOR = 10.86)
Number of subjects: 823
Study 35368996 — intervention group
Group type: EXPERIMENTAL
Intervention: Be a Mom (self-guided web-based intervention)
Number of subjects: 800
Study 34035052 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 32826199 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual dodgeball game (Dodgeality)
Number of subjects: 0
Study 37288499 — intervention group
Group type: EXPERIMENTAL
Intervention: Active photobiomodulation (PBM) therapy, 808 nm, 15 min, 16.5 J/cm2, self-applied at home for 3 months
Number of subjects: 50
Study 37288499 — intervention group
Group type: COMPARATOR
Intervention: Sham photobiomodulation therapy, self-applied at home for 3 months
Number of subjects: 50
Study 33705182 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 93
Study 33705182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 34486528 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise plus nutrient-dense weight maintenance diet
Number of subjects: 134
Study 34486528 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise plus weight loss by moderate caloric restriction
Number of subjects: 134
Study 35861931 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted version for Mexico (Mantente REAL)
Number of subjects: 36
Study 35861931 — intervention group
Group type: EXPERIMENTAL
Intervention: Original intervention from the USA (keepin' it REAL) translated into Spanish
Number of subjects: 36
Study 35861931 — intervention group
Group type: COMPARATOR
Intervention: Control condition (treatment as usual)
Number of subjects: 36
Study 35822251 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic surgery (HALS)
Number of subjects: 124
Study 35822251 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic-assisted surgery (LAS)
Number of subjects: 124
Study 34272322 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617 (6.0 GBq per cycle)
Number of subjects: 64
Study 34272322 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617 (7.4 GBq per cycle)
Number of subjects: 64
Study 34272322 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (177Lu-PSMA-617)
Number of subjects: 64
Study 34272322 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617
Number of subjects: 64
Study 34859632 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 1361
Study 34859632 — intervention group
Group type: COMPARATOR
Intervention: Non-prophylactic antibiotics
Number of subjects: 1361
Study 32507149 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) for 10 minutes at 35 Hz and 2 mm amplitude
Number of subjects: 21
Study 32507149 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) remained on the platform for 10 minutes without vibratory stimulus
Number of subjects: 21
Study 36399038 — intervention group
Group type: EXPERIMENTAL
Intervention: Photon-counting CT (PCCT)
Number of subjects: 7
Study 36399038 — intervention group
Group type: COMPARATOR
Intervention: Standard energy-integrating detector (EID) CT
Number of subjects: 7
Study 33789311 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol® (2 × 50 mg/day for a total of 12 weeks)
Number of subjects: 76
Study 32325914 — intervention group
Group type: EXPERIMENTAL
Intervention: ANS-LD (15 mg.kg−1.bw−1)
Number of subjects: 10
Study 32325914 — intervention group
Group type: EXPERIMENTAL
Intervention: ANS-HD (30 mg.kg−1.bw−1)
Number of subjects: 10
Study 32325914 — intervention group
Group type: COMPARATOR
Intervention: PLA
Number of subjects: 10
Study 33788006 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates
Number of subjects: 60
Study 33788006 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit-based exercise
Number of subjects: 60
Study 33788006 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual activities)
Number of subjects: 60
Study 32958537 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based financing (PBF)
Number of subjects: 0
Study 32958537 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 33121341 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental theory of personality intervention
Number of subjects: 535
Study 33121341 — intervention group
Group type: COMPARATOR
Intervention: Alternative educational control condition
Number of subjects: 535
Study 32803412 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR) group (n = 143) aiming to decrease energy intake by 25%
Number of subjects: 218
Study 32803412 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR) group (n = 143)
Number of subjects: 218
Study 32803412 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum (AL) group (n = 75)
Number of subjects: 218
Study 34863330 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral lyophilised FMT for 8 weeks
Number of subjects: 35
Study 34863330 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules for 8 weeks
Number of subjects: 35
Study 34863330 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of FMT for 48 weeks (for responders)
Number of subjects: 35
Study 34863330 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of FMT for 48 weeks (for responders)
Number of subjects: 35
Study 36378093 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises (PREs) performed once a day for 4 weeks in addition to standard treatment
Number of subjects: 44
Study 36378093 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 44
Study 33775464 — intervention group
Group type: EXPERIMENTAL
Intervention: Question Prompt List (QPL) with 35 hand-specific questions
Number of subjects: 126
Study 33775464 — intervention group
Group type: COMPARATOR
Intervention: AskShareKnow group with 3 generic questions
Number of subjects: 126
Study 35103237 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided ACB with 14 ml 0.25% levobupivacaine and 100 mcg clonidine
Number of subjects: 77
Study 32389236 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice rehabilitation post-radiotherapy
Number of subjects: 74
Study 32389236 — intervention group
Group type: COMPARATOR
Intervention: Irradiated control group
Number of subjects: 74
Study 36180878 — intervention group
Group type: EXPERIMENTAL
Intervention: Scoliosis group (intervention)
Number of subjects: 50
Study 36180878 — intervention group
Group type: COMPARATOR
Intervention: Lumbar disc herniation group (control)
Number of subjects: 50
Study 36180878 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 34167279 — intervention group
Group type: EXPERIMENTAL
Intervention: ASL
Number of subjects: 39
Study 34167279 — intervention group
Group type: EXPERIMENTAL
Intervention: TOF MRA
Number of subjects: 39
Study 34167279 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ASL and TOF MRA
Number of subjects: 39
Study 35138259 — intervention group
Group type: EXPERIMENTAL
Intervention: Unguided internet-based cognitive behavioral therapy (ICBT) for 4 weeks
Number of subjects: 312
Study 35138259 — intervention group
Group type: EXPERIMENTAL
Intervention: Three Good Things (TGT) exercise for 4 weeks
Number of subjects: 312
Study 35138259 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (WLC)
Number of subjects: 312
Study 35138259 — intervention group
Group type: EXPERIMENTAL
Intervention: ICBT
Number of subjects: 312
Study 35138259 — intervention group
Group type: EXPERIMENTAL
Intervention: TGT
Number of subjects: 312
Study 34065178 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi-based stroke rehabilitation program
Number of subjects: 34
Study 34065178 — intervention group
Group type: COMPARATOR
Intervention: Stroke-symptom management program
Number of subjects: 34
Study 33384890 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicolor scanning laser ophthalmoscopy (MC‐SLO)
Number of subjects: 40
Study 33384890 — intervention group
Group type: COMPARATOR
Intervention: Color fundus photography (CFP)
Number of subjects: 40
Study 33801969 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment + virtual reality
Number of subjects: 43
Study 33801969 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 43
Study 34338615 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy smokers
Number of subjects: 97
Study 34338615 — intervention group
Group type: COMPARATOR
Intervention: Light smokers
Number of subjects: 97
Study 34338615 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 97
Study 32646519 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-hospital care capacity assessment
Number of subjects: 163
Study 32646519 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency response capabilities
Number of subjects: 163
Study 32646519 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency medical services policy
Number of subjects: 163
Study 32646519 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional emergency response systems
Number of subjects: 163
Study 34112520 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg twice daily
Number of subjects: 8144
Study 34112520 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion sustained-release 150 mg twice daily
Number of subjects: 8144
Study 34112520 — intervention group
Group type: COMPARATOR
Intervention: Nicotine patch 21 mg once daily
Number of subjects: 8144
Study 33135436 — intervention group
Group type: EXPERIMENTAL
Intervention: Single preoperative dose of 20 mg dexamethasone and a postoperative saline injection (Group B)
Number of subjects: 165
Study 33135436 — intervention group
Group type: EXPERIMENTAL
Intervention: Two perioperative doses of 10 mg dexamethasone (Group C)
Number of subjects: 165
Study 33135436 — intervention group
Group type: COMPARATOR
Intervention: Two perioperative saline injections (Group A, placebo)
Number of subjects: 165
Study 33774503 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task training involving auditory-vocal and visual-manual tasks
Number of subjects: 0
Study 33774503 — intervention group
Group type: COMPARATOR
Intervention: Single-task performance
Number of subjects: 0
Study 33774503 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task performance
Number of subjects: 0
Study 36121791 — intervention group
Group type: EXPERIMENTAL
Intervention: MegaShield®
Number of subjects: 140
Study 36121791 — intervention group
Group type: COMPARATOR
Intervention: Guardix‐SG®
Number of subjects: 140
Study 33762645 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma
Number of subjects: 55
Study 33762645 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish
Number of subjects: 55
Study 33762645 — intervention group
Group type: COMPARATOR
Intervention: Tetric N‐Bond self‐etch system
Number of subjects: 55
Study 35656469 — intervention group
Group type: EXPERIMENTAL
Intervention: Persian medicine diet combined with Western medicine-based diet
Number of subjects: 20
Study 35656469 — intervention group
Group type: COMPARATOR
Intervention: Western medicine-based diet
Number of subjects: 20
Study 34034359 — intervention group
Group type: EXPERIMENTAL
Intervention: Health workers training to promote healthy feeding practices
Number of subjects: 20
Study 33570497 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) technology
Number of subjects: 600
Study 33570497 — intervention group
Group type: EXPERIMENTAL
Intervention: High users of IVR (received >75% of reminders)
Number of subjects: 600
Study 33570497 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate use of IVR (51%-75%)
Number of subjects: 600
Study 33570497 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR technology
Number of subjects: 600
Study 35550486 — intervention group
Group type: EXPERIMENTAL
Intervention: Doubling usual standing time (60 minutes five times per week)
Number of subjects: 25
Study 35550486 — intervention group
Group type: COMPARATOR
Intervention: Usual standing time (30 minutes three times per week)
Number of subjects: 25
Study 34702015 — intervention group
Group type: EXPERIMENTAL
Intervention: Winning algorithm (3D-UNet model)
Number of subjects: 243
Study 34702015 — intervention group
Group type: COMPARATOR
Intervention: 2nd to 5th place ensemble solutions
Number of subjects: 243
Study 32381052 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Habits Plus telephone-based program
Number of subjects: 0
Study 32381052 — intervention group
Group type: EXPERIMENTAL
Intervention: Time2bHealthy online program
Number of subjects: 0
Study 32381052 — intervention group
Group type: COMPARATOR
Intervention: Comparison group receiving written materials
Number of subjects: 0
Study 34706071 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intervention program based on a cognitive-behavioral approach
Number of subjects: 48
Study 34706071 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 34897973 — intervention group
Group type: EXPERIMENTAL
Intervention: Students' education (4 sessions of 60 minutes)
Number of subjects: 261
Study 34897973 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers' education (2 sessions of 90 minutes)
Number of subjects: 261
Study 34897973 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 261
Study 34919862 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal HIV testing and treatment (annual HIV and multidisease testing, universal ART eligibility, patient-centred care)
Number of subjects: 8198
Study 34919862 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline testing and medical care according to national guidelines)
Number of subjects: 8198
Study 32434067 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut Oral Immunotherapy (OIT)
Number of subjects: 20
Study 32434067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 33874981 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Prolastin® (plasma‐purified alpha‐1 antitrypsin) at 120mg/kg of body weight for 4 weeks
Number of subjects: 36
Study 33874981 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Prolastin® (plasma‐purified alpha‐1 antitrypsin) at 120mg/kg of body weight (single dose) followed by 0.9% sodium chloride for 3 weeks
Number of subjects: 36
Study 33874981 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride intravenously once per week for four weeks (placebo)
Number of subjects: 36
Study 33874981 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Prolastin® (plasma‐purified alpha‐1 antitrypsin)
Number of subjects: 36
Study 33333987 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric single-leg decline squat exercise (SLDSe) with 6 s execution time (EG1)
Number of subjects: 36
Study 33333987 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric single-leg decline squat exercise (SLDSe) with 3 s execution time (EG2)
Number of subjects: 36
Study 33333987 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric single-leg decline squat exercise (SLDSe) (EG1 and EG2)
Number of subjects: 36
Study 33333987 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 36
Study 35551299 — intervention group
Group type: EXPERIMENTAL
Intervention: Vistusertib (125 mg twice daily for 2 days per week) + Anastrozole (1 mg daily)
Number of subjects: 75
Study 35551299 — intervention group
Group type: COMPARATOR
Intervention: Anastrozole (1 mg daily)
Number of subjects: 75
Study 35551299 — intervention group
Group type: EXPERIMENTAL
Intervention: Vistusertib + Anastrozole
Number of subjects: 75
Study 35551299 — intervention group
Group type: COMPARATOR
Intervention: Anastrozole
Number of subjects: 75
Study 35933686 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster Care Intervention (FCG)
Number of subjects: 68
Study 35933686 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiving quality in foster care at 42 months
Number of subjects: 68
Study 35933686 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 68
Study 35933686 — intervention group
Group type: COMPARATOR
Intervention: Never-institutionalized group
Number of subjects: 68
Study 33420936 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevent-Teach-Reinforce-for-Young-Children (PTR-YC) program
Number of subjects: 35
Study 33420936 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation fidelity and treatment acceptability
Number of subjects: 35
Study 32396257 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole patch (up to 64 mg/d)
Number of subjects: 0
Study 32396257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32396257 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole extended-release tablet (up to 16 mg/d)
Number of subjects: 0
Study 34408046 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory multiplex PCR and procalcitonin (experimental strategy)
Number of subjects: 450
Study 34408046 — intervention group
Group type: COMPARATOR
Intervention: Conventional microbiological investigations (usual strategy)
Number of subjects: 450
Study 32404133 — intervention group
Group type: EXPERIMENTAL
Intervention: I'M FINE intervention (individualized aerobic exercise and coaching)
Number of subjects: 90
Study 32404133 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 90
Study 32404133 — intervention group
Group type: EXPERIMENTAL
Intervention: I'M FINE intervention
Number of subjects: 90
Study 35731062 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin-A (BTX-A) nerve block
Number of subjects: 52
Study 35731062 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 52
Study 32783351 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab 2 mg/kg every 4 weeks (arm 1)
Number of subjects: 182
Study 32783351 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab 4 mg/kg every 8 weeks (arm 2)
Number of subjects: 182
Study 32783351 — intervention group
Group type: COMPARATOR
Intervention: Canakinumab (discontinued)
Number of subjects: 182
Study 33855222 — intervention group
Group type: EXPERIMENTAL
Intervention: Teneligliptin 20 mg once daily (qd) for 24 weeks
Number of subjects: 0
Study 33855222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33855222 — intervention group
Group type: EXPERIMENTAL
Intervention: Teneligliptin 20 mg qd at Week 12
Number of subjects: 0
Study 33855222 — intervention group
Group type: COMPARATOR
Intervention: Placebo at Week 12
Number of subjects: 0
Study 33855222 — intervention group
Group type: EXPERIMENTAL
Intervention: Teneligliptin
Number of subjects: 0
Study 32623087 — intervention group
Group type: EXPERIMENTAL
Intervention: IRIS group (n=82)
Number of subjects: 292
Study 32623087 — intervention group
Group type: COMPARATOR
Intervention: Non-IRIS group (n=210)
Number of subjects: 292
Study 35555002 — intervention group
Group type: EXPERIMENTAL
Intervention: VR Oculus Quest 2TM headset
Number of subjects: 0
Study 35555002 — intervention group
Group type: EXPERIMENTAL
Intervention: AlioscopyTM autostereoscopic screen
Number of subjects: 0
Study 35555002 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed physical model
Number of subjects: 0
Study 34864802 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose photodynamic therapy (61 patients)
Number of subjects: 160
Study 34864802 — intervention group
Group type: COMPARATOR
Intervention: High-density subthreshold micropulse laser treatment (62 patients)
Number of subjects: 160
Study 32692971 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial MAT
Number of subjects: 31
Study 32692971 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral MAT
Number of subjects: 31
Study 34998276 — intervention group
Group type: EXPERIMENTAL
Intervention: ECAP-controlled, closed-loop SCS
Number of subjects: 134
Study 34998276 — intervention group
Group type: COMPARATOR
Intervention: Fixed-output, open-loop SCS
Number of subjects: 134
Study 35927676 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-deoxy-D-glucose (2-DG) 90 mg/kg/day plus standard of care (SOC)
Number of subjects: 110
Study 35927676 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-deoxy-D-glucose (2-DG) 90 mg/kg/day plus SOC
Number of subjects: 110
Study 35927676 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) only
Number of subjects: 110
Study 35381407 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (IV) administration of nadroparin 3800 IU over 4 hours
Number of subjects: 60
Study 35381407 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous (SC) administration of nadroparin
Number of subjects: 60
Study 35381407 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (IV) administration
Number of subjects: 60
Study 35381407 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous (SC) administration
Number of subjects: 60
Study 34313803 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol beverage (M BAC ≈ 0.08%)
Number of subjects: 81
Study 34313803 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 81
Study 32658497 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss (BWL)
Number of subjects: 110